Catalyst Wire Dossier Catalyst Wire Dossier

Naltrexone SR/Bupropion SR

naltrexone/bupropion sustained-release · Orexigen Therapeutics
Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for Naltrexone SR/Bupropion SR, covering 2012-11-02 to 2014-11-21. Get the full timeline:

Most recent: Clinical Trial Update: A Safety and Efficacy Study of Naltrexone SR/Bupropion SR in Overweight and Obese Subjects [Phase 3]

See pricing